BioNxt Solutions Inc. (CVE:BNXT)

PRESS RELEASE

published on 09/29/2025 at 09:05, 1 year 1 month ago

BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization
BioNxt Solutions provides update on Cladribine sublingual thin-film drug reformulation program, targeting treatment of multiple sclerosis with improved bioavailability and patient adherence

Multiple Sclerosis Cladribine Neurological Disorders BioNxt Solutions Drug Delivery Technologies
BRIEF

published on 09/20/2025 at 03:50, 1 year 1 month ago

BioNxt Solutions lève des actions pour régler sa dette

Actions Ordinaires Règlement De La Dette Solutions BioNxt Valeurs Mobilières Canadiennes Accord De Dette
BRIEF

published on 09/20/2025 at 03:50, 1 year 1 month ago

BioNxt Solutions Completes Shares for Debt Settlement

Common Shares Debt Settlement Debt Agreement Canadian Securities BioNxt Solutions
PRESS RELEASE

published on 09/20/2025 at 03:45, 1 year 1 month ago

BioNxt Solutions Announces Closing of Shares for Debt Settlement
BioNxt Solutions Inc. announces successful debt settlement with creditor, issuing common shares and making cash payment. Company focuses on bioscience innovation and drug delivery technologies

Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Technologies Bioscience Innovation
BRIEF

published on 09/20/2025 at 01:35, 1 year 1 month ago

BioNxt Solutions Inc. Engages Capital Markets Advisor and Investor Relations Professionals

Stock Options Investor Relations Capital Markets BioNxt Solutions Terry Lynch
BRIEF

published on 09/20/2025 at 01:35, 1 year 1 month ago

BioNxt Solutions Inc. fait appel à des conseillers en marchés financiers et à des professionnels des relations avec les investisseurs.

Relations Avec Les Investisseurs Marchés Des Capitaux Options Sur Actions Solutions BioNxt Terry Lynch
PRESS RELEASE

published on 09/20/2025 at 01:30, 1 year 1 month ago

Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms

BioNxt Solutions Inc. Terry Lynch Investor Relations Professionals Bioscience Innovations Drug Delivery Platforms
BRIEF

published on 09/15/2025 at 09:10, 1 year 1 month ago

BioNxt Progresses with Semaglutide Oral Film Program

Patent Filing Prototype Development BioNxt Semaglutide ODF GLP-1 Market
BRIEF

published on 09/15/2025 at 09:10, 1 year 1 month ago

BioNxt progresse avec son programme de films oraux à base de sémaglutide

Dépôt De Brevet Développement De Prototypes BioNxt Semaglutide ODF Marché Du GLP-1
PRESS RELEASE

published on 09/15/2025 at 09:05, 1 year 1 month ago

BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies

Drug Delivery Semaglutide BioNxt GLP-1 Market Proof-of-concept

Published on 11/10/2026 at 02:45, 1 hour 43 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 5 hours 18 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 5 hours 28 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 5 hours 56 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 6 hours 13 minutes ago

Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley

View all ACCESSWIRE

Published on 11/10/2026 at 01:20, 3 hours 8 minutes ago

US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 23:35, 4 hours 53 minutes ago

KPS to Acquire MM Packaging from MM Group
Published on 11/09/2026 at 22:54, 5 hours 34 minutes ago

EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 6 hours 18 minutes ago

Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 6 hours 23 minutes ago

Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders

View all EQS

Published on 11/09/2026 at 18:30, 9 hours 58 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 9 hours 58 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 10 hours 43 minutes ago

Weekly share buyback
Published on 11/09/2026 at 17:45, 10 hours 43 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 10 hours 43 minutes ago

Déclaration des droits de vote à fin octobre 2026

View all LES ECHOS COMFI WIRE

News